Results 201 to 210 of about 43,876 (313)

TREATMENT PERSISTENCY WITH RIVASTIGMINE AND DONEPEZIL IN A LARGE STATE MEDICAID PROGRAM [PDF]

, 2005
Gurkirpal Singh, Simu K. Thomas, Steve Arcona, Vijayabharathi Lingala, Alka Mithal   +4 more
openalex   +1 more source

Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors. [PDF]

Drug Healthc Patient Saf
Chikermane SG, Li J, Aparasu RR.
europepmc   +1 more source

β-cyclodextrin cross-linked metal organic frameworks as a new sensing candidate for donepezil hydrochloride potentiometric sensors. [PDF]

BMC Chem
El-Attar RO, Abdelhameed RM, Khaled E.
europepmc   +1 more source

The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study

, 2003
Éduardo Bruera, Florian Strasser, Loren Shen, J. Lynn Palmer, Jie Willey, Larry Driver, Allen W. Burton   +6 more
openalex   +1 more source

[O2‐01‐01]: Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard‐ratio analysis [PDF]

, 2005
Leon J. Thal, Ronald G. Thomas, Michael Grundman, David A. Bennett, Rachelle S. Doody, Steven H. Ferris, Douglas Galasko, Shelia Jin, Allan I. Levey, Ronald C. Petersen   +9 more
openalex   +1 more source

Potential of rutin from <i>Rhizophora mucronata</i> leaves as a Inhibitor of Kelch-like ECH-associated protein 1/Nuclear factor erythroid 2 related factor 2 Keap1/Nrf2): An <i>in silico</i> study for Alzheimer's therapy. [PDF]

J Adv Pharm Technol Res
Saputri LO, Permatasari L, Harahap HS, Rosyidi RM, Rivarti AW, Prihatina LM, Rahayu Z, Azariani W.   +7 more
europepmc   +1 more source

P3–457: Treatment of severe Alzheimer's disease with donepezil: Results from a 24–week, parallel, placebo–controlled study in Japan [PDF]

, 2006
Akira Homma, Itaru Arimoto, Kasumi Daidoji, Toshio Ohbayashi, Hideo Ozawa   +4 more
openalex   +1 more source

Donepezil von STADA [PDF]

NeuroTransmitter, 2012
openaire   +4 more sources

The anti‐amnesic and neuroprotective effects of donepezil against amyloid β_25‐35 peptide‐induced toxicity in mice involve an interaction with the σ₁ receptor [PDF]

, 2006
Johann Meunier, John R. Ieni, Tangui Maurice   +2 more
openalex   +1 more source

Clinical efficacy of donepezil combined with nerve growth factor in the treatment of patients with Parkinson's disease dementia and its impact on adiponectin and soluble tumor necrosis factor-alpha receptor-1. [PDF]

Pak J Med Sci
Hu M, Ye J.
europepmc   +1 more source